NIM
NEOS Investment Management Portfolio holdings
AUM
$8.08B
This Quarter Return
+5.84%
1 Year Return
+24.46%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.31B
AUM Growth
+$3.31B
(+36%)
Cap. Flow
+$835M
Cap. Flow
% of AUM
25.23%
Top 10 Holdings %
Top 10 Hldgs %
34.05%
Holding
588
New
19
Increased
514
Reduced
16
Closed
9
Top Buys
| 1 |
Broadcom
AVGO
|
$67.9M |
| 2 |
Vanguard Russell 2000 ETF
VTWO
|
$64.4M |
| 3 |
Apple
AAPL
|
$36.2M |
| 4 |
Microsoft
MSFT
|
$35.6M |
| 5 |
NVIDIA
NVDA
|
$34.7M |
Top Sells
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$1.21M |
| 2 |
Super Micro Computer
SMCI
|
$812K |
| 3 |
Exelixis
EXEL
|
$572K |
| 4 |
MREO
Mereo BioPharma
MREO
|
$511K |
| 5 |
Vale
VALE
|
$440K |
Sector Composition
| 1 | Technology | 32.75% |
| 2 | Healthcare | 12.38% |
| 3 | Communication Services | 9.77% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Essex Property Trust
ESS
$16.8B
| $264K | 0.01% |
894
| – | – |
|
552
Zebra Technologies
ZBRA
$15.6B
| $264K | 0.01% |
712
| – | – |
|
553
Brown-Forman Class B
BF.B
$13.8B
| $254K | 0.01% |
+5,167
| New | +$254K |
|
|
ITCI
554
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $248K | 0.01% |
3,388
| – | – |
|
555
Align Technology
ALGN
$9.94B
| $247K | 0.01% |
972
| – | – |
|
556
BioNTech
BNTX
$24.2B
| $245K | 0.01% |
+2,067
| New | +$245K |
|
557
Franklin Resources
BEN
$13.2B
| $245K | 0.01% |
12,164
+2,436
| +25% | +$49.1K |
|
558
Factset
FDS
$13.9B
| $244K | 0.01% |
530
| – | – |
|
559
Canadian National Railway
CNI
$60.3B
| $240K | 0.01% |
2,050
+195
| +11% | +$22.8K |
|
560
Everest Group
EG
$14.5B
| $237K | 0.01% |
605
| – | – |
|
561
Campbell Soup
CPB
$9.38B
| $237K | 0.01% |
+4,838
| New | +$237K |
|
562
Catalyst Pharmaceutical
CPRX
$2.51B
| $226K | 0.01% |
11,352
| – | – |
|
563
Ferrari
RACE
$87.7B
| $220K | 0.01% |
469
-129
| -22% | -$60.6K |
|
|
PARA
564
DELISTED
Paramount Global Class B
PARA
| $218K | 0.01% |
20,513
+4,060
| +25% | +$43.1K |
|
565
Labcorp
LH
$22.8B
| $217K | 0.01% |
+973
| New | +$217K |
|
566
Avery Dennison
AVY
$13.2B
| $215K | 0.01% |
972
| – | – |
|
567
Skye Bioscience
SKYE
$105M
| $215K | 0.01% |
54,871
+23,224
| +73% | +$90.8K |
|
568
Snap-on
SNA
$16.9B
| $213K | 0.01% |
+736
| New | +$213K |
|
569
Sarepta Therapeutics
SRPT
$1.77B
| $213K | 0.01% |
1,706
| – | – |
|
570
Jasper Therapeutics
JSPR
$44.9M
| $211K | 0.01% |
+11,219
| New | +$211K |
|
571
Packaging Corp of America
PKG
$19.5B
| $210K | 0.01% |
+973
| New | +$210K |
|
572
Domino's
DPZ
$15.9B
| $209K | 0.01% |
487
| – | – |
|
573
Axsome Therapeutics
AXSM
$6.16B
| $209K | 0.01% |
+2,327
| New | +$209K |
|
574
IDEX
IEX
$12.2B
| $208K | 0.01% |
+972
| New | +$208K |
|
575
Pool Corp
POOL
$11.4B
| $202K | 0.01% |
+537
| New | +$202K |
|